JFA
NVRO

JNBA Financial Advisors’s NEVRO CORP. NVRO Stock Holding History

JNBA Financial Advisors’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-160
Closed -$9K – 739
2018
Q3 		$9K Buy
+160
New +$10K ﹤0.01% 390
2016
Q4 		– Sell
-74
Closed -$8K – 1399
2016
Q3 		$8K Buy
+74
New +$6.68K ﹤0.01% 1105

Other funds holding NVRO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

JNBA Financial Advisors's NVRO Position: Q4 2018 in Review

JNBA Financial Advisors sold out of NEVRO CORP. (NVRO) in Q4 2018, closing a stake of 160 shares — an estimated $9K sold.

JNBA Financial Advisors first reported a position in NVRO in Q3 2016 and held it in 2 quarters. The position peaked at $9K in Q3 2018. 157 funds tracked by Wall St. Rank hold NVRO as of Q4 2018.

  • JNBA Financial Advisors reported no remaining NEVRO CORP. position as of Q4 2018 after selling out during the quarter.
  • JNBA Financial Advisors sold 160 NEVRO CORP. shares in Q4 2018, an estimated $9K.
  • JNBA Financial Advisors first reported a position in NEVRO CORP. in Q3 2016 and held it in 2 quarters.
  • JNBA Financial Advisors's NEVRO CORP. position peaked at $9K in Q3 2018.
  • 157 funds tracked by Wall St. Rank held NEVRO CORP. as of Q4 2018.

Based on JNBA Financial Advisors's 13F filing for Q4 2018, filed 7 Feb 2019.